Methyl jasmonate inhibits MPP+-induced neuroinflammation and oxidation in BV2 microglia cells Via NF-kB (p65)/Nrf2 pathway

Keyphrases

• Neuroinflammation 100%
• BV2 Microglia 100%
• 1-methyl-4-phenylpyridinium 100%
• Nrf2 Pathway 100%
• NF-kB p65 100%
• Methyl Jasmonate (MeJA) 100%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 10%
• Neuroprotective Effect 10%
• Neurotoxicity 10%
• Nuclear factor-κB 10%
• Induced Expression 10%
• Pro-inflammatory Enzymes 10%
• Statistical Analysis 5%
• Apoptosis 5%
• DNA Binding 5%
• Parkinson's Disease 5%
• Inflammatory Cytokines 5%
• Cyclooxygenase-2 5%
• Inducible Nitric Oxide Synthase 5%
• Antioxidant System 5%
• Dimethyl Sulfoxide 5%
• Treatment Group 5%
• Cell Viability 5%
• Nuclear Accumulation 5%
• Neurotoxin 5%
• One-way Analysis of Variance 5%
• Induced Production 5%
• Neurodegenerative Movement Disorder 5%
• Cytokine Levels 5%
• BV-2 5%
• Parkinson's Disease Model 5%
• Enzyme Level 5%
• Tukey Test 5%
• Neuroprotective Role 5%
• Anti-apoptotic 5%
• Parkinson's Disease Treatment 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Nervous System Inflammation 100%
• Transcription Factor Nrf2 100%
• 1 Methyl 4 Phenylpyridinium 100%
• Jasmonic Acid Methyl Ester 100%
• Parkinson's Disease 15%
• Neuroprotective Agent 15%
• Cytokine 10%
• Neurotoxicity 10%
• Antioxidant 5%
• Motor Dysfunction 5%
• Anti-Inflammatory Drug 5%
• Treatment Group 5%
• Dimethyl Sulfoxide 5%
• Combination Therapy 5%
• Cell Viability 5%
• Neurotoxin 5%
• Antiapoptotic 5%

Agricultural and Biological Sciences

• Nervous System Inflammation 100%
• Microglia 100%
• MPP+ 100%
• Methyl Jasmonate 100%
• Neurotoxicity 10%
• Neuroprotective Effect 10%
• Cytokine 10%
• Programmed Cell Death 5%
• Antiinflammatory 5%
• Analysis of Variance 5%
• Cell Viability 5%
• Dimethyl Sulfoxide 5%